|
|
||||||||
1Physiological Laboratory, 2Section of Cardiovascular Biology, Department of Biochemistry, and 3Department of Pharmacology, University of Cambridge, United Kingdom
Submitted 12 December 2004 ; accepted in final form 25 May 2005
Heart failure leading to ventricular arrhythmogenesis is a major cause of clinical mortality and has been associated with a leak of sarcoplasmic reticular Ca2+ into the cytosol due to increased open probabilities in cardiac ryanodine receptor Ca2+-release channels. Caffeine similarly increases such open probabilities, and so we explored its arrhythmogenic effects on intact murine hearts. A clinically established programmed electrical stimulation protocol adapted for studies of isolated intact mouse hearts demonstrated that caffeine (1 mM) increased the frequency of ventricular tachycardia from 0 to 100% yet left electrogram duration and latency unchanged during programmed electrical stimulation, thereby excluding slowed conduction as a cause of arrhythmogenesis. We then used fluorescence measurements of intracellular Ca2+ concentration in isolated mouse ventricular cells to investigate parallel changes in Ca2+ homeostasis associated with these arrhythmias. Both caffeine (1 mM) and FK506 (30 µM) reduced electrically evoked cytosolic Ca2+ transients yet increased the frequency of spontaneous Ca2+-release events. Diltiazem (1 µM) but not nifedipine (1 µM) pretreatment suppressed these increases in frequency. Identical concentrations of diltiazem but not nifedipine correspondingly suppressed the arrhythmogenic effects of caffeine in whole hearts. These findings thus directly implicate spontaneous Ca2+ waves in triggered arrhythmogenesis in intact hearts.
mouse; ryanodine receptor; programmed electrical stimulation; ventricular tachycardia; arrhythmia
This article has been cited by other articles:
![]() |
J. V. Gerasimenko, G. Lur, M. W. Sherwood, E. Ebisui, A. V. Tepikin, K. Mikoshiba, O. V. Gerasimenko, and O. H. Petersen Pancreatic protease activation by alcohol metabolite depends on Ca2+ release via acid store IP3 receptors PNAS, June 30, 2009; 106(26): 10758 - 10763. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Ghais, Y. Zhang, A. A. Grace, and C. L.-H. Huang Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts Exp Physiol, February 1, 2009; 94(2): 240 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-a. Zhang, R. A. Tuft, L. M. Lifshitz, K. E. Fogarty, J. J. Singer, and H. Zou Caffeine-activated large-conductance plasma membrane cation channels in cardiac myocytes: characteristics and significance Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2448 - H2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Stokoe, R. Balasubramaniam, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/ murine hearts modelling the Brugada syndrome J. Physiol., May 15, 2007; 581(1): 255 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Katra, T. Oya, G. S. Hoeker, and K. R. Laurita Ryanodine receptor dysfunction and triggered activity in the heart Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2144 - H2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. George, S. A. Rogers, B. M.A. Bertrand, R. E.A. Tunwell, N. L. Thomas, D. S. Steele, E. V. Cox, C. Pepper, C. J. Hazeel, W. C. Claycomb, et al. Alternative Splicing of Ryanodine Receptors Modulates Cardiomyocyte Ca2+ Signaling and Susceptibility to Apoptosis Circ. Res., March 30, 2007; 100(6): 874 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Tocchetti, W. Wang, J. P. Froehlich, S. Huke, M. A. Aon, G. M. Wilson, G. Di Benedetto, B. O'Rourke, W. D. Gao, D. A. Wink, et al. Nitroxyl Improves Cellular Heart Function by Directly Enhancing Cardiac Sarcoplasmic Reticulum Ca2+ Cycling Circ. Res., January 5, 2007; 100(1): 96 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Stokoe, G. Thomas, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/{Delta} murine hearts modelling long QT syndrome 3 J. Physiol., January 1, 2007; 578(1): 69 - 84. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |